This Government Contract opportunity from Department Of Defense was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Pharmaceutical Supply – Guaifenesin Extended-Release Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract involves the supply of FDA-compliant Guaifenesin Extended-Release Tablets with a dosage of 600 mg, packaged in bottles containing 500 tablets each. The agreement covers comprehensive requirements including proper labeling, adherence to shelf-life standards, and compliance with hazard communication regulations to ensure product safety and regulatory conformity. The procurement is designated as a subcontract under the Department of Defense's Medical Supply Chain Pharmaceutical FSA. The place of performance is specified as Fort Bragg, with the solicitation posted on May 18, 2026, and responses due by May 26, 2026. The contract falls under NAICS code 325412, which pertains to pharmaceutical manufacturing. While specific details such as the solicitation number and direct points of contact are not provided, the official opportunity is accessible via a Department of Defense electronic procurement platform. This contract reflects a critical procurement effort aimed at supporting medical supply chain needs with high-standard pharmaceutical products.
General Info
Agency
NAICS
Place of Performance
FORT BRAGG, NC, 28310, USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
